Huda Alalami, Jeremy David Rudnick, Joanna Wilson, Almar Guevarra, Rebecca Naor, Jethro Lisien Hu. "Real-world experience with vorasidenib in IDH-mutant gliomas: Tolerability, adverse events, and access in patients who did not meet INDIGO trial eligibility criteria.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e14029